Literature DB >> 31223347

FLEXIBLE RISK PREDICTION MODELS FOR LEFT OR INTERVAL-CENSORED DATA FROM ELECTRONIC HEALTH RECORDS.

Noorie Hyun1, Li C Cheung1, Qing Pan2, Mark Schiffman1, Hormuzd A Katki1.   

Abstract

Electronic health records are a large and cost-effective data source for developing risk-prediction models. However, for screen-detected diseases, standard risk models (such as Kaplan-Meier or Cox models) do not account for key issues encountered with electronic health record data: left-censoring of pre-existing (prevalent) disease, interval-censoring of incident disease, and ambiguity of whether disease is prevalent or incident when definitive disease ascertainment is not conducted at baseline. Furthermore, researchers might conduct novel screening tests only on a complex two-phase subsample. We propose a family of weighted mixture models that account for left/interval-censoring and complex sampling via inverse-probability weighting in order to estimate current and future absolute risk: we propose a weakly-parametric model for general use and a semiparametric model for checking goodness of fit of the weakly-parametric model. We demonstrate asymptotic properties analytically and by simulation. We used electronic health records to assemble a cohort of 33,295 human papillomavirus (HPV) positive women undergoing cervical cancer screening at Kaiser Permanente Northern California (KPNC) that underlie current screening guidelines. The next guidelines would focus on HPV typing tests, but reporting 14 HPV types is too complex for clinical use. National Cancer Institute along with KPNC conducted a HPV typing test on a complex subsample of 9258 women in the cohort. We used our model to estimate the risk due to each type and grouped the 14 types (the 3-year risk ranges 21.9-1.5) into 4 risk-bands to simplify reporting to clinicians and guidelines. These risk-bands could be adopted by future HPV typing tests and future screening guidelines.

Entities:  

Keywords:  B-splines; HIV; Mixture model; interval censoring; two-phase sampling; weighted likelihood

Year:  2017        PMID: 31223347      PMCID: PMC6586434          DOI: 10.1214/17-AOAS1036

Source DB:  PubMed          Journal:  Ann Appl Stat        ISSN: 1932-6157            Impact factor:   2.083


  7 in total

1.  Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results.

Authors:  Philip E Castle; Walter K Kinney; Xiaonan Xue; Li C Cheung; Julia C Gage; Nancy E Poitras; Thomas S Lorey; Hormuzd A Katki; Nicolas Wentzensen; Mark Schiffman
Journal:  J Natl Cancer Inst       Date:  2019-08-01       Impact factor: 13.506

2.  A comparison of high-grade cervical abnormality risks in women living with and without human immunodeficiency virus undergoing routine cervical-cancer screening.

Authors:  Philip E Castle; Brian Befano; Mark Schiffman; Nicolas Wentzensen; Thomas Lorey; Nancy Poitras; Marianne Hyer; Li C Cheung
Journal:  Prev Med       Date:  2022-07-08       Impact factor: 4.637

3.  The Improving Risk Informed HPV Screening (IRIS) Study: Design and Baseline Characteristics.

Authors:  Julia C Gage; Tina Raine-Bennett; Mark Schiffman; Megan A Clarke; Li C Cheung; Nancy E Poitras; Nicole E Varnado; Hormuzd A Katki; Philip E Castle; Brian Befano; Malini Chandra; Greg Rydzak; Thomas Lorey; Nicolas Wentzensen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-11-17       Impact factor: 4.090

4.  A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs.

Authors:  Maria Demarco; Noorie Hyun; Olivia Carter-Pokras; Tina R Raine-Bennett; Li Cheung; Xiaojian Chen; Anne Hammer; Nicole Campos; Walter Kinney; Julia C Gage; Brian Befano; Rebecca B Perkins; Xin He; Cher Dallal; Jie Chen; Nancy Poitras; Marie-Helene Mayrand; Francois Coutlee; Robert D Burk; Thomas Lorey; Philip E Castle; Nicolas Wentzensen; Mark Schiffman
Journal:  EClinicalMedicine       Date:  2020-04-25

5.  2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation.

Authors:  Li C Cheung; Didem Egemen; Xiaojian Chen; Hormuzd A Katki; Maria Demarco; Amy L Wiser; Rebecca B Perkins; Richard S Guido; Nicolas Wentzensen; Mark Schiffman
Journal:  J Low Genit Tract Dis       Date:  2020-04       Impact factor: 3.842

6.  A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines.

Authors:  Maria Demarco; Didem Egemen; Tina R Raine-Bennett; Li C Cheung; Brian Befano; Nancy E Poitras; Thomas S Lorey; Xiaojian Chen; Julia C Gage; Philip E Castle; Nicolas Wentzensen; Rebecca B Perkins; Richard S Guido; Mark Schiffman
Journal:  J Low Genit Tract Dis       Date:  2020-04       Impact factor: 3.842

7.  Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines.

Authors:  Didem Egemen; Li C Cheung; Xiaojian Chen; Maria Demarco; Rebecca B Perkins; Walter Kinney; Nancy Poitras; Brian Befano; Alexander Locke; Richard S Guido; Amy L Wiser; Julia C Gage; Hormuzd A Katki; Nicolas Wentzensen; Philip E Castle; Mark Schiffman; Thomas S Lorey
Journal:  J Low Genit Tract Dis       Date:  2020-04       Impact factor: 3.842

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.